Cryptogenic fibrosing alveolitis (Q41588324)

4 October 2017

1 reference

title

Cryptogenic fibrosing alveolitis (English)

1 reference

4 October 2017

M Chan-Yeung

1

1 reference

4 October 2017

N L Müller

series ordinal

2

1 reference

4 October 2017

language of work or name

English

0 references

publication date

1 August 1997

1 reference

4 October 2017

1 reference

4 October 2017

volume

350

1 reference

4 October 2017

issue

9078

1 reference

4 October 2017

page(s)

651-656

1 reference

Lung biopsy in the diagnosis of diffuse lung disease

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Mortality rates from cryptogenic fibrosing alveolitis in seven countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

The epidemiology of interstitial lung diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Cryptogenic fibrosing alveolitis and Epstein-Barr virus: an association?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Type I collagen formation in rat type II alveolar cells immortalised by viral gene products

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Cryptogenic fibrosing alveolitis: clinical features and their influence on survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Usual interstitial pneumonia: correlation of CT with clinical, functional, and radiologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Fibrosing alveolitis: CT-pathologic correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Comparative accuracy of high resolution computed tomography and chest radiography in the diagnosis of chronic diffuse infiltrative lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

The sensitivity of high-resolution CT in detecting idiopathic pulmonary fibrosis proved by open lung biopsy. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Disease progression in usual interstitial pneumonia compared with desquamative interstitial pneumonia. Assessment with serial CT

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Corticosteroids and the treatment of idiopathic pulmonary fibrosis. Past, present, and future

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Cyclosporin as a treatment for interstitial lung disease of unknown aetiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

1 reference

7 January 2021

Accuracy of mortality data for interstitial lung diseases in New Mexico, USA

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Rising mortality from cryptogenic fibrosing alveolitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Pulmonary fibrosis deaths in the United States, 1979-1991. An analysis of multiple-cause mortality data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis. The BAL Cooperative Group Steering Committee.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Anatomic distribution and histopathologic patterns in diffuse lung disease: correlation with HRCT.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Idiopathic pulmonary fibrosis. Quantitative assessment of lung pathology. Comparison of a semiquantitative and a morphometric histopathologic scoring system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Detection of Epstein-Barr virus in lymphocytic interstitial pneumonia by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Localisation of a pulmonary autoantigen in cryptogenic fibrosing alveolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Natural History and Treated Course of Usual and Desquamative Interstitial Pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Clinical significance of pulmonary function tests. Pulmonary function testing in interstitial pulmonary disease. What does it tell us?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Determinants of survival in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Prognosis of cryptogenic fibrosing alveolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Computed tomography-guided bronchoalveolar lavage in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Relationship between cells obtained by bronchoalveolar lavage and survival in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Idiopathic pulmonary fibrosis: progression of honeycombing at thin-section CT

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Chronic diffuse infiltrative lung disease: determination of the diagnostic value of clinical data, chest radiography, and CT and Bayesian analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Fibrosing alveolitis: prognostic implication of ground-glass attenuation at high-resolution CT

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Parenchymal opacification in chronic infiltrative lung diseases: CT-pathologic correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

The alphabet soup revisited: the chronic interstitial pneumonias in the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Diffuse infiltrative lung disease: a new scheme for description

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

End-stage lung disease: CT findings in 61 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: pathologic-CT correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Comparison of video thoracoscopic lung biopsy to open lung biopsy in the diagnosis of interstitial lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

OPEN-LUNG BIOPSY IN DUFFUSE PULMONARY DISEASE.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Video-assisted thoracic surgery in the elderly. A review of 307 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Use of intermittent, intravenous cyclophosphamide for idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Outcome of subjects with idiopathic pulmonary fibrosis who fail corticosteroid therapy. Implications for further studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

New approaches to the treatment of pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Effect of intermittent high dose parenteral corticosteroids on the alveolitis of idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Colchicine in the treatment of pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Azathioprine Combined with Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis: A Prospective Double-blind, Randomized, Placebo-controlled Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Response to methotrexate in fibrosing alveolitis associated with connective tissue disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

Diffuse interstitial pneumonitis. Clinicopathologic correlations in 20 patients treated with prednisone/azathioprine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906303-4

7 January 2021

10.1016/S0140-6736(97)06303-4

Identifiers

DOI

1 reference

4 October 2017

1 reference